163 related articles for article (PubMed ID: 7536990)
21. Post-transfusion hepatitis revisited.
Ismay SL; Thomas S; Fellows A; Keller A; Kenrick KG; Archer GT; Wylie BR; Cossart YE
Med J Aust; 1995 Jul; 163(2):74-7. PubMed ID: 7542359
[TBL] [Abstract][Full Text] [Related]
22. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
[TBL] [Abstract][Full Text] [Related]
23. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
[TBL] [Abstract][Full Text] [Related]
24. HCV and blood transfusion.
Reesink HW; van der Poel CL; Cuypers HT; Lelie PN
Arch Virol Suppl; 1992; 4():241-3. PubMed ID: 1280507
[TBL] [Abstract][Full Text] [Related]
25. HCV antibodies in Hungarian blood donations. Experiences collected by ELISA tests, immunoblot assays and polymerase chain reaction and protocols for donor management.
Héjjas M; Medgyesi GA; Falus A; Hajnal A; Forster T; Szabó J
Transfus Med; 1994 Dec; 4(4):273-80. PubMed ID: 7534174
[TBL] [Abstract][Full Text] [Related]
26. [Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months].
Durand F; Danic B; Tardivel R; Semana G; Gouezec H; Martinot M; Marcellin P; Beauplet A
Transfus Clin Biol; 2000 Jun; 7(3):242-50. PubMed ID: 10919211
[TBL] [Abstract][Full Text] [Related]
27. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674
[TBL] [Abstract][Full Text] [Related]
28. Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.
O'Riordan JM; Conroy A; Nourse C; Yap PL; McDonald GS; Kaminski G; Leong K; Lawlor E; Davoren A; Strong K; Davidson F; Lloyd A; Power J
Transfus Med; 1998 Dec; 8(4):303-8. PubMed ID: 9881424
[TBL] [Abstract][Full Text] [Related]
29. Should hepatitits-C virus antibody-positive donors be excluded from kidney donation?
Pouteil-Noble C; Tardy JC; Chossegros P; Trepo C; Aymard M; Touraine JL
Transpl Int; 1992; 5 Suppl 1():S44-6. PubMed ID: 14621728
[TBL] [Abstract][Full Text] [Related]
30. [Follow-up of blood donors with positive serology for hepatitis C virus and their recipients is insufficient].
Bonaguidi-Magniaux M; Pilette C; Oberti F; Bidet ML; Calès P
Gastroenterol Clin Biol; 1996; 20(8-9):663-8. PubMed ID: 8977814
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
[TBL] [Abstract][Full Text] [Related]
32. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
[TBL] [Abstract][Full Text] [Related]
33. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden.
Mattsson L; Grillner L; von Sydow M; Bergdahl S; Weiland O
Infection; 1991; 19(5):309-12. PubMed ID: 1666063
[TBL] [Abstract][Full Text] [Related]
34. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
Hitzler WE; Runkel S
Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
[TBL] [Abstract][Full Text] [Related]
35. [A study on the patterns of early specific antibody response in patients with posttransfusion hepatitis C].
Hao F; Li MD
Zhonghua Nei Ke Za Zhi; 1994 Sep; 33(9):593-6. PubMed ID: 7536148
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
[TBL] [Abstract][Full Text] [Related]
37. Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second-generation anti-hepatitis C virus assay.
Huang YY; Yang SS; Wu CH; Shih WS; Huang CS; Chen PH; Lin YM; Shen CT; Chen DS
Transfusion; 1994 Aug; 34(8):661-5. PubMed ID: 7521077
[TBL] [Abstract][Full Text] [Related]
38. Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays.
Lelie PN; Cuypers HT; Reesink HW; van der Poel CL; Winkel I; Bakker E; van Exel-Oehlers PJ; Vallari D; Allain JP; Mimms L
J Med Virol; 1992 Jul; 37(3):203-9. PubMed ID: 1331309
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
Gonçales NS; Costa FF; Vassallo J; Gonçales FL
Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus among blood donors: follow-up study.
Alonso C; Pedroso ML; de Sanjosé S; Montcharmont P; Chèvre JM; Boucaud MJ; Lambert V; Cortey ML; Trépo C
Transfusion; 1994 Jun; 34(6):527-30. PubMed ID: 8023395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
